LONDON, March 19, 2013 /PRNewswire/ -- Smith & Nephew (LSE:SN NYSE: SNN), the global medical technology business, announces the showcasing of the JOURNEY™ II Bi-Cruciate Stabilized (BCS) knee replacement at this year's American Academy of Orthopaedic Surgeons (AAOS) meeting in Chicago, March 19-23.
The JOURNEY II BCS knee sets a new standard in knee implant performance by restoring more normal motion. This is achieved through the reproduction of both the shapes of the joint's hard surfaces and the normal force behavior of the soft tissues, such as ligament and muscle firing patterns. As a result, the soft tissue's readjustment to new shapes and forces after surgery is minimized, helping to return the patient's stride to its natural rhythm.
"The JOURNEY II BCS knee takes knee performance beyond the current standards for fit and alignment and gives patients the complex motion, strength and stability of a human knee," said Gaurav Agarwal , President of Smith & Nephew's joint reconstruction business. "You don't have to ask patients if it feels like a normal knee—you can see it in their gait and in their post-op x-rays. We redefined knee implant function when we launched the original JOURNEY knee in 2005, and with JOURNEY II BCS we have again outpaced traditional knee replacement technology."
This latest innovation is the result of intense research and design, and the development of new PHYSIOLOGICAL MATCHING™ Technology. Using its LifeMOD™ human simulation software, Smith & Nephew engineers were able to conduct proprietary analysis of the bone, ligament and muscle forces that impact the knee, and then account for those forces within the design of an implant that restores anatomic shapes and normal motion. <
|SOURCE Smith & Nephew|
Copyright©2012 PR Newswire.
All rights reserved